Catalent
CTLT
#1737
Rank
NZ$19.94 B
Marketcap
NZ$109.88
Share price
0.00%
Change (1 day)
15.86%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$10.67 Billion

According to Catalent's latest financial reports the company's total liabilities are NZ$10.67 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30NZ$10.05 B9.42%
2022-06-30NZ$9.18 B32.86%
2021-06-30NZ$6.91 B4.44%
2020-06-30NZ$6.62 B14.25%
2019-06-30NZ$5.79 B13.93%
2018-06-30NZ$5.08 B36.36%
2017-06-30NZ$3.73 B8.42%
2016-06-30NZ$3.44 B-6.76%
2015-06-30NZ$3.68 B-6.61%
2014-06-30NZ$3.95 B-9.01%
2013-06-30NZ$4.34 B-0.15%
2012-06-30NZ$4.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ$0.64 B-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.93 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$12.80 B 19.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
NZ$0.55 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA